Companies: 48,687 Total Market Cap: 127170027423520.77

BML

TYO-4694
Healthcare Medical - Diagnostics & Research
Rank #10322
Market Cap 787.91 M
Volume 384
Price 20.20
Change (%) 0.85%
Country or region Japan Japan

BML's latest marketcap:

787.91 M

As of May 4, 2025, BML's market capitalization has reached $787.91 M. According to our data, BML is the 10322th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 787.91 M
Revenue (ttm) 974.32 M
Net Income (ttm) 41.94 M
Shares Out 39.01 M
EPS (ttm) 1.08
Forward PE 19.47
Ex-Dividend Date March 28, 2025
Earnings Date May 9, 2025
Market Cap Chart
Data Updated: May 4, 2025

BML's yearly market capitalization.

BML has seen its market value drop from ¥130.25 B to ¥115.26 B since 2020, representing a total decrease of 11.50% and an annual compound decline rate (CAGR) of 2.78%.
Date Market Cap Change (%)
May 1, 2025 ¥115.26 B 1.69%
December 30, 2024 ¥113.35 B -3.08%
December 29, 2023 ¥116.95 B -11.25%
December 30, 2022 ¥131.77 B -9.09%
December 30, 2021 ¥144.94 B 11.28%
December 30, 2020 ¥130.25 B

Company Profile

About BML, Inc.

BML, Inc. is a leading provider of laboratory testing and related services in Japan. Established in 1955 and headquartered in Tokyo, the company offers a comprehensive range of diagnostic and analytical solutions for medical, pharmaceutical, and environmental sectors.

Core Services

  • Laboratory Testing: Biochemical, hematologic, immunological, DNA analysis, and microbiological tests for medical and pharmaceutical applications.
  • Specialized Testing: Focus areas include tumorology, infectious diseases, diabetes, hypertension, allergies, and genetic studies.
  • Automation Systems: Development of Frontier and Symphony automation systems for streamlined pre-processing and testing procedures.
  • Medical Information Systems: Electronic medical chart services and preventive medicine solutions.

Additional Services

  • Food Sanitation Testing: Microorganism testing for raw materials, processed foods, and environmental hygiene assessments.
  • Environmental Testing: Drinking water, wastewater, and indoor contaminant monitoring, including dioxin analysis.
  • Work Environment Services: Measurement of hazardous substances like ethylene oxide gas, formaldehyde, and organic solvents.
  • Pharmaceutical & Genetic Services: Consulting for drug approvals, investigative analysis, human genome studies, and gene expression testing.
  • Dental Testing: Services for dental caries and periodontal disease diagnostics.

BML, Inc. continues to innovate in laboratory science, supporting healthcare, food safety, and environmental sustainability across Japan.

Frequently Asked Questions

As of May 4, 2025, BML (including the parent company, if applicable) has an estimated market capitalization of $787.91 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

BML global market capitalization ranking is approximately 10322 as of May 4, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Japan
Founded 1955
IPO Date n/a
Employees 4,513
CEO Kensuke Kondo
Sector Healthcare
Industry Medical - Diagnostics & Research
Address 5-21-3 Sendagaya
Tokyo, 151-0051
Japan